F
Ford Motor Company
F lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
OCG
Oriental Culture Holding Ltd.
There isn't enough reported data to score OCG yet.
F Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Strong |
F's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
OCG Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
OCG's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
F PE Valuation
F has no meaningful PE right now: it lost money over the past year.
OCG PE Valuation
OCG has no meaningful PE right now: it lost money over the past year.
F Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect F's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
OCG Forward outlook
There aren't enough analyst estimates for OCG to show an outlook.
F Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.78 | โ |
| Q3 2026 | -$1.97 | -270% |
| Q2 2026 | -$1.87 | -340% |
| Q1 2026 | -$1.55 | -224% |
| Q4 2025 | -$2.06 | -241% |
| Q3 2025 | $1.16 | +32% |
| Q2 2025 | $0.78 | -19% |
| Q1 2025 | $1.25 | +29% |
| Q4 2024 | $1.46 | +35% |
F has swung to a loss: it lost $1.97 per share over the past year, after a profit the year before.
OCG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | -$107.26 | +$11.54 |
| Q4 2024 | -$118.80 | +$435.60 |
| Q4 2023 | -$554.40 | -212% |
OCG has the edge over F in the latest year-over-year earnings comparison.
F Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $49.5B | -2% |
| Q2 2026 | $48.3B | -3.8% |
| Q1 2026 | $43.3B | +6.4% |
| Q4 2025 | $45.9B | -4.8% |
| Q3 2025 | $50.5B | +9.4% |
| Q2 2025 | $50.2B | +5% |
| Q1 2025 | $40.7B | -5% |
| Q4 2024 | $48.2B | +4.9% |
F has the edge over OCG in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.9% | -0.1 points |
| Q2 2026 | 1.3% | +0.3 points |
| Q1 2026 | 5.4% | +4.6 points |
| Q4 2025 | -25% | -28 points |
| Q3 2025 | 3.1% | +1.2 points |
| Q2 2025 | 1% | -2.9 points |
| Q1 2025 | 0.8% | -2.1 points |
| Q4 2024 | 2.5% | +3.1 points |
F's operating margin was 2.9% last quarter, about level with the same quarter a year ago.
OCG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $1.9M | +203% |
| Q4 2024 | $622.7K | -61% |
| Q4 2023 | $1.6M | -91% |
| Q4 2022 | $17.8M | -53% |
| Q4 2021 | $37.6M | +116% |
| Q4 2020 | $17.4M | +212% |
| Q4 2019 | $5.6M | +4.6% |
OCG's revenue has slid since its 2021 peak: $2M last quarter, down 95% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -203% | -232 points |
| Q4 2024 | -513% | -523 points |
| Q4 2023 | -274% | -322 points |
| Q4 2022 | 15% | -66 points |
| Q4 2021 | 29% | -21 points |
| Q4 2020 | 9.4% | N/A |
| Q4 2019 | 48% | N/A |
| Q2 2019 | 80% | N/A |
OCG's operating margin was โ203% last quarter, down 232 points from the same quarter a year ago.
F Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.1B | -40% |
| Q2 2026 | $2B | -54% |
| Q1 2026 | -$1.1B | -157% |
| Q4 2025 | $1.1B | +108% |
| Q3 2025 | $5.3B | +50% |
| Q2 2025 | $4.2B | +24% |
| Q1 2025 | $1.9B | +$2.6B |
| Q4 2024 | $530M | +169% |
F still generates free cash flow, though less than at its 2020 peak: $5.1B over the past year.
OCG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | -$4.1M | -218% |
| Q4 2023 | $3.4M | +$5.4M |
| Q4 2022 | -$1.9M | -$1.3M |
| Q4 2021 | -$573.5K | -107% |
| Q4 2020 | $8.1M | +302% |
| Q4 2019 | $2M | -36% |
| Q2 2019 | $7.3M | +9184% |
| Q4 2018 | $3.1M | +7928% |
OCG's free cash flow has turned negative after years in the green: โ$3M over the past year.
F Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.5x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q1 2026 | -2.0x | Net Cash |
| Q4 2025 | -3.4x | Net Cash |
| Q3 2025 | -2.4x | Net Cash |
| Q2 2025 | -2.2x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | -1.8x | Net Cash |
F has more cash than debt.
OCG Net Leverage
OCG's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
F Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 19.6 | Oversold |
F's weekly RSI is 41 (neutral) and its Stochastic is 20 (oversold).
OCG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 24.6 | Oversold |
| Stochastic | 30.4 | Neutral |
OCG's weekly RSI is 25 (oversold) and its Stochastic is 30 (neutral).
F PE vs Consumer Cyclical Sector
| Metric | F | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | โ |
F has no meaningful PE right now: it lost money over the past year.
OCG PE vs Consumer Cyclical Sector
| Metric | OCG | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | โ |
OCG has no meaningful PE right now: it lost money over the past year.
F Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.2 | 2.5% below |
| 20 week MA | $13.3 | 11% below |
| 50 week MA | $13.4 | 11% below |
| 100 week MA | $12.1 | 2% below |
| 200 week MA | $12.1 | 1.4% below |
F is in a downtrend: it's below all five of its weekly moving averages, and 1.4% below its 200-week average.
OCG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.63 | 0.6% below |
| 20 week MA | $1.64 | 1.2% below |
| 50 week MA | $46.0 | 96% below |
| 100 week MA | $1,165.0 | 100% below |
| 200 week MA | $1,218.6 | 100% below |
OCG is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
F Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.36 | $8.86 | -5.3% |
| 2021 | $8.86 | $20.3 | +129% |
| 2022 | $20.3 | $11.4 | -44% |
| 2023 | $11.4 | $12.2 | +7.3% |
| 2024 | $12.2 | $10.0 | -18% |
| 2025 | $10.0 | $13.3 | +33% |
| 2026 YTD | $13.3 | $11.9 | -11% |
F has the edge over OCG on returns for 2026, with the stronger performance.
OCG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $19,800.0 | $17,886.0 | -9.7% |
| 2021 | $17,886.0 | $16,632.0 | -7% |
| 2022 | $16,632.0 | $1,881.0 | -89% |
| 2023 | $1,881.0 | $943.8 | -50% |
| 2024 | $943.8 | $772.2 | -18% |
| 2025 | $772.2 | $56.8 | -93% |
| 2026 YTD | $56.8 | $1.62 | -97% |
OCG has finished every year since 2020 lower, and it's down 97% so far in 2026.